Zerella, JR;
Homan, CC;
Arts, P;
Lin, X;
Spinelli, SJ;
Venugopal, P;
Babic, M;
Brautigan, PJ;
Truong, L;
Arriola-Martinez, LA;
et al.
Zerella, JR; Homan, CC; Arts, P; Lin, X; Spinelli, SJ; Venugopal, P; Babic, M; Brautigan, PJ; Truong, L; Arriola-Martinez, LA; Moore, S; Hollins, R; Parker, WT; Nguyen, H; Kassahn, KS; Branford, S; Feurstein, SK; Larcher, L; Sicre De Fontbrune, F; Demirdas, S; de Munnik, S; Poirel, HA; Brichard, B; Mansour, S; Gordon, K; ERG Variants Research Network; Wlodarski, MW; Koppayi, AL; Dobbins, S; Mutsaers, PGNJ; Nichols, KE; Oak, N; DeMille, D; Mao, R; Crawford, A; McCarrier, J; Basel, D; Flores-Daboub, J; Drazer, MW; Phillips, K; Poplawski, NK; Birdsey, GM; Pirri, D; Ostergaard, P; Simons, A; Godley, LA; Ross, DM; Hiwase, DK; Soulier, J; Brown, AL; Carmichael, CL; Scott, HS; Hahn, CN
(2024)
Germline ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.
Blood.
ISSN 1528-0020
https://doi.org/10.1182/blood.2024024607
SGUL Authors: Ostergaard, Pia
Abstract
The genomics era has facilitated discovery of new genes predisposing to bone marrow failure (BMF) and hematological malignancy (HM). We report the discovery of ERG as a novel autosomal dominant BMF/HM predisposition gene. ERG is a highly constrained transcription factor critical for definitive hematopoiesis, stem cell function and platelet maintenance. ERG colocalizes with other transcription factors including RUNX1 and GATA2 on promoters/enhancers of genes orchestrating hematopoiesis. We identified a rare heterozygous ERG missense variant in 3 thrombocytopenic individuals from one family and 14 additional ERG variants in unrelated individuals with BMF/HM including 2 de novo cases and 3 truncating variants. Phenotypes associated with pathogenic germline ERG variants included cytopenias (thrombocytopenia, neutropenia, pancytopenia) and HMs (acute myeloid leukemia, myelodysplastic syndrome, acute lymphoblastic leukemia) with onset before 40 years. Twenty ERG variants (19 missense, 1 truncating) including 3 missense population variants were functionally characterized. Thirteen potentially pathogenic ETS domain missense variants displayed loss-of-function characteristics disrupting transcriptional transactivation, DNA-binding and/or nuclear localization. Selected variants overexpressed in mouse fetal liver cells failed to drive myeloid differentiation and cytokine-independent growth in culture, and to promote acute erythroleukemia when transplanted into mice, concordant with these variants being loss-of-function. Four individuals displayed somatic genetic rescue by copy neutral loss of heterozygosity. Identification of predisposing germline ERG variants has clinical implications for patient/family diagnosis, counselling, surveillance, and treatment strategies including selection of bone marrow donors or cell/gene therapy.
Statistics
Item downloaded times since 24 Jul 2024.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |